Compare ARK Genomic Revolution ETF (ARKG) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Opendoor Technologies Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Opendoor Technologies Inc trades at $4.83 (market cap $4.60B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | OPEN | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $10.52 |
52-Week Low | $23.09 | $0.78 |
Market Cap | — | $4.60B |
Enterprise Value | — | $4.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Opendoor Technologies (OPEN) trades at $4.764, down 10.11% today, with a market cap around $4.8B. Technicals show a bullish moving average signal but overbought RSI levels, while fundamentals reveal declining revenue ($4.37B in 2025) and deep losses (net margin -35.25%). Recent news highlights CEO leadership changes and AI-driven operational shifts, including India exit to cut costs.
Outlook remains challenging due to persistent unprofitability and high debt, though analyst consensus leans Hold (65.39%). Key risks include housing market sensitivity and execution of new business model; potential upside hinges on margin improvement and seasonal housing rebounds in late 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
